TD Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
TD Asset Management's SLXP Position: Q2 2015 in Review
TD Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,592 shares — an estimated $448K sold.
TD Asset Management first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $3.45M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- TD Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
- TD Asset Management sold 2,592 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $448K.
- TD Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
- TD Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.45M in Q4 2014.
- 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.
Based on TD Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.